J&J Medical Connect
RYBREVANT®

(amivantamab-vmjw)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

Can I Take RYBREVANT if I am Pregnant or Breastfeeding?

Last Updated: 09/05/2024

summary

Here is a passage from the RYBREVANT PATIENT INFORMATION which may be helpful to address your question:

Can I take RYBREVANT if I am pregnant or breastfeeding?

Before you receive RYBREVANT, tell your healthcare provider about all of your medical conditions, including if you:

  • are pregnant or plan to become pregnant. RYBREVANT can harm your unborn baby.1
    • Females who are able to become pregnant:
      • Your healthcare provider should do a pregnancy test before you start treatment with RYBREVANT.
      • You should use effective birth control (contraception) during treatment and for 3 months after your last dose of RYBREVANT.
      • Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with RYBREVANT.
  • are breastfeeding or plan to breastfeed. It is not known if RYBREVANT passes into your breast milk. Do not breastfeed during treatment and for 3 months after your last dose of RYBREVANT.1

ADDITIONAL INFORMATION

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for RYBREVANT.1

 

References

1 RYBREVANT (amivantamab-vmjw) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/RYBREVANT-pi.pdf.